US Patent 9867822 Cannabinoid receptor modulators
Patent 9867822 was granted and assigned to Arena Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9867822 Cannabinoid receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
